TP53 and cancer: The mutation rate of the tumour suppressor gene p53 in human malignant tumours is 30%-50%, and the presence of one mutated p53 protein in different combinations of p53 tetramers effectively interferes with the function of the entire tetramer, rendering its apoptotic function completely inactive (54).